Navigation Links
USCIS Tightens Vaccination Requirements
Date:7/23/2008

Full line of vaccines for Immigration and Naturalization ready at Passport

Health

BALTIMORE, July 23 /PRNewswire/ -- New vaccine requirements will affect anyone who is applying for an immigrant visa for entry into the U.S. and anyone seeking adjustment of status for permanent residence. Applicants must show proof of vaccinations against vaccine-preventable diseases, as recommended by the U.S. Advisory Committee on Immunization Practices. Passport Health, a company that specializes in Travel Medicine and vaccinations, announced today that all 165 of it offices throughout the U.S. are fully stocked with all vaccines required for immigration and naturalization.

Current vaccine requirement includes: Influenza, Pneumococcal, Hepatitis A&B, TDaP, Polio, Varicella, and MMR. Zoster (Shingles) vaccine for anyone over age 60 and HPV/cervical cancer vaccine for women 11-26 are new requirements.

Since 9/11, enforcement of immigration laws has tightened. "After 9/11, there were dramatic changes in immigration law and its enforcement," said Sheela Murthy, president of Murthy Law Firm, one of the country's leading immigration law practices. "It is good that our country is protecting its residents against diseases that can be brought from foreign countries or that can easily spread through our population." Murthy attended Harvard Law School and has been practicing immigration law for over 20 years.

As an immigrant herself, Murthy has seen how the internet has revolutionized the way her clients search for information regarding legal requirements, including where to get the vaccines they need. "When I had to get my vaccinations you went blindfolded and there weren't many choices."

This is where Passport Health comes in. The company makes sorting through immunization requirements for immigration or international travel easy. Trained nurses and doctors also offer destination-specific travel-health information a
'/>"/>

SOURCE Passport Health
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
2. Booster vaccination may help with possible future avian influenza pandemic
3. Gender, time of day affect response to vaccination
4. Finding suggests novel ways to boost vaccination or natural defenses
5. NVIC Launches Stand Up Be Counted Campaign to Protect Voluntary Vaccination Decisions in America
6. PA Health Department Provides Hepatitis B Vaccinations, Discusses Risk Factors
7. Mothers less likely to pursue HPV vaccination for youngest daughters
8. Mothers Less Likely to Pursue HPV Vaccination for Youngest Daughters
9. Parents Follow Pediatrician Advice on MMR Vaccinations
10. Parents follow pediatrician advice on administering MMR vaccinations
11. MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... WASHINGTON, Dec. 2 EIN...site providing in-depth news on breast cancer. , ...re patients are finding out that information is on... , Responding to the growing demand for accur...ors, screening procedures and drugs to treat it, E...
(Date:12/2/2008)..., A study led by researchers at The University of...e body from lung cancer. , The research, publish...demy of Sciences , USA and funded by a 72,000 gran... the tumour suppressor gene, LIMD1, is responsible...er paving the way for possible new treatments and...
(Date:12/2/2008)..., The Center for the Study of Law, Science, and T...w at Arizona State University will host an interna...iz., on the future of forensic science, with speci...he U.S. National Academy of Sciences, "Identifying..., In addition to experts from universities such a...
(Date:12/2/2008)... LONGMONT, Colo., Dec. 2 MicroPhag...oday that Lynn M. Taussig, MD has joined,the comp...nd CEO of National,Jewish Medical and Research Ce...for studying respiratory diseases, from 1993 to 20...gy. , "I have followed MicroPhage extensive...
Breaking Medicine News(10 mins):Health News:EIN News Introduces 'Breast Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2Health News:Gene which protects against lung cancer identified 2Health News:MicroPhage Selects Lynn Taussig, MD for Board of Directors 2
...study has found that smoking may hamper alcoholics... nine months period of alcohol abstinence . Abou... who take alcoholism treatment are chronic smokers... may interfere with the neurocognitive recovery of...
.../actress Mandy Moore admits that she doesn't mind ... The 23-year-old insisted that its part of her job...t is not a 'personal thing'. "It's not a personal...hat I have to do for my job: shape up a little bit...
...nual UN report on illegal drugs has said that opiu...rol . The World Drug Report says over 90 percent ...mes from Afghanistan. According to a BBC report,...um poppies increased dramatically in the country, ...
...people with diabetes can lose weight if they use p...tion sizes, a new study has found. The study was...lgary, Alberta, Canada led by Dr Sue D. Pedersen, ...onducted a six-month controlled trial of commercia...
Other Medicine News:Health News:Smoking Hampers Alcoholics' Neurocognitive Recovery During Abstinence 2Health News:Smoking Hampers Alcoholics' Neurocognitive Recovery During Abstinence 3Health News:Using Portion-control Dishes can Help Obese Diabetics Lose Weight 2
(Date:12/1/2008)... SINGAPORE, Dec. 1 S*BIO Pte Ltd ...ical trial of SB1518, a potent and orally-active J...alia for patients with chronic idiopathic myelofib... evaluate the safety and tolerability of SB1518 in... 50 patients. The Phase 1 part of the study will ...
(Date:12/1/2008)... Baby Girl with Hypophosphatasia Treated With ENB...re in Winnipeg , , MONTREAL, Dec. 1 /PRNews...ch company focused on developing novel therapeutic... the first infant patient in its clinical program ...ating Enzyme Replacement Therapy (ERT) with ENB-00...
(Date:12/1/2008)... , Abstinence is still the best policy , ...ire/ -- A new study from Mayo Clinic finds the use...ating alcoholic hepatitis, an acute inflammation o...ohol. The results of the study are published in th...w.gastrojournal.org/ ). , , VIDEO ALERT: A...
(Date:12/1/2008)... KVISTGARD, Denmark, December 1 /PRNewswire-F...ued in 2007 with the intent to procure an MVA-base...s and Government Services,Canada, on behalf of th...rded,a contract to Bavarian Nordic for the delive...es intend to use IMVAMUNE(R) as part of the,count...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3BioVex to Report Phase II Clinical Trial Results of OncoVEX GM CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2100 1BioVex to Report Phase II Clinical Trial Results of OncoVEX GM CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2100 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2100 3Anesiva Announces May 22 2008 Presentation at Citi Investment Research Global HealthCare Conference 19576 1New Gene Methylation Test for Prostate Cancer Available 2096 1Jazz Pharmaceuticals to Present at Investor Conferences 19573 1
...(MARKET WIRE) -- July 02, 2007 -- DOR BioPharma, I...ed today that the,first results from testing of a ...T-VACC™, have been published in the journal,... Infection and,Immunity, v. 75, p. 3043 ). These r...immunity elicited by a multivalent vaccine,that is...
... Update to Timeline for Second Pivotal Phase 3 Tri...Call/ -- Advanced Life,Sciences Holdings, Inc. , t...ficacy data from Trial CL-06, the first of two,piv...e safety and,effectiveness of cethromycin, a novel...nity acquired pneumonia (CAP). The Company,also pr...
Other Medicine Technology:DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),
Steroid-eluting, screw-in pacing lead
Tendril SDX is one of the world's thinnest, extendable/retractable pacing leads. Implantable with a 7 F introducer, the lead's reduced body diameter is designed to lower the incidence of venous obstr
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase.
Medicine Products: